• Study Resource
  • Explore Categories
    • Arts & Humanities
    • Business
    • Engineering & Technology
    • Foreign Language
    • History
    • Math
    • Science
    • Social Science

    Top subcategories

    • Advanced Math
    • Algebra
    • Basic Math
    • Calculus
    • Geometry
    • Linear Algebra
    • Pre-Algebra
    • Pre-Calculus
    • Statistics And Probability
    • Trigonometry
    • other →

    Top subcategories

    • Astronomy
    • Astrophysics
    • Biology
    • Chemistry
    • Earth Science
    • Environmental Science
    • Health Science
    • Physics
    • other →

    Top subcategories

    • Anthropology
    • Law
    • Political Science
    • Psychology
    • Sociology
    • other →

    Top subcategories

    • Accounting
    • Economics
    • Finance
    • Management
    • other →

    Top subcategories

    • Aerospace Engineering
    • Bioengineering
    • Chemical Engineering
    • Civil Engineering
    • Computer Science
    • Electrical Engineering
    • Industrial Engineering
    • Mechanical Engineering
    • Web Design
    • other →

    Top subcategories

    • Architecture
    • Communications
    • English
    • Gender Studies
    • Music
    • Performing Arts
    • Philosophy
    • Religious Studies
    • Writing
    • other →

    Top subcategories

    • Ancient History
    • European History
    • US History
    • World History
    • other →

    Top subcategories

    • Croatian
    • Czech
    • Finnish
    • Greek
    • Hindi
    • Japanese
    • Korean
    • Persian
    • Swedish
    • Turkish
    • other →
 
Profile Documents Logout
Upload
Mental Retirement and Non-Contributory Pensions for the Elderly
Mental Retirement and Non-Contributory Pensions for the Elderly

... significant effect of retirement on cognitive functioning. All these studies are based on industrialized countries where social security coverage is extended and therefore retirement regulation can offer a convincing instrument. The analysis of the “mental retirement” effect is more challenging in t ...
The relationship of health beliefs knowledge of disease and social
The relationship of health beliefs knowledge of disease and social

... A great deal o f research has been done to develop treatments that alleviate the physical symptoms o f inflammatory bowel disease (IBD) In addition, the effects o f pharmaceutical and surgical interventions on a patient’s health-related quality o f life (HRQOL) are currently acknowledged as importan ...
Communication: Is it Mishearing or Misinterpretation? For a Virtual
Communication: Is it Mishearing or Misinterpretation? For a Virtual

Nails—They Mean More Than You Think!—Part 1
Nails—They Mean More Than You Think!—Part 1

Management of COPD
Management of COPD

Betahistine for Ménière`s disease or syndrome (Review) - E
Betahistine for Ménière`s disease or syndrome (Review) - E

SUBSTANCE USE DISORDERS
SUBSTANCE USE DISORDERS

Document
Document

A Model of PSychoSociAl SuPPoRt - National Multiple Sclerosis
A Model of PSychoSociAl SuPPoRt - National Multiple Sclerosis

Brain-Derived Neurotrophic Factor Reduces Amyloidogenic
Brain-Derived Neurotrophic Factor Reduces Amyloidogenic

Slides Only - Curriculum for the Hospitalized Aging Medical Patient
Slides Only - Curriculum for the Hospitalized Aging Medical Patient

Paget Disease of the Bone, Radiologic and Pathologic Correlation
Paget Disease of the Bone, Radiologic and Pathologic Correlation

IL-10 Alters Immunoproteostasis in APP Mice, Increasing Plaque
IL-10 Alters Immunoproteostasis in APP Mice, Increasing Plaque

National Amyloidosis Centre News
National Amyloidosis Centre News

briefing paper on dementia diagnosis
briefing paper on dementia diagnosis

Alzheimer`s Disease Amyloid-b Links Lens and Brain
Alzheimer`s Disease Amyloid-b Links Lens and Brain

Intratympanic gentamicin for Ménière`s disease or syndrome
Intratympanic gentamicin for Ménière`s disease or syndrome

full program with abstracts
full program with abstracts

Methods - Laboratory for Advanced Brain Signal Processing
Methods - Laboratory for Advanced Brain Signal Processing

Cyclooxygenase-2 (COX-2) in Inflammatory and Degenerative Brain
Cyclooxygenase-2 (COX-2) in Inflammatory and Degenerative Brain

Report of the Council on Science and Public Health - Report 3-A-13
Report of the Council on Science and Public Health - Report 3-A-13

Diseases
Diseases

Amyloid Precursor Protein in Cortical Neurons: Coexistence of Two
Amyloid Precursor Protein in Cortical Neurons: Coexistence of Two

Dementia Care in the aCute hospital setting
Dementia Care in the aCute hospital setting

Myotonic Dystrophy Type I (Steinert`s Disease)
Myotonic Dystrophy Type I (Steinert`s Disease)

< 1 2 3 4 5 6 7 ... 47 >

Alzheimer's disease



Alzheimer's disease (AD), also known as Alzheimer disease, or just Alzheimer's, accounts for 60% to 70% of cases of dementia. It is a chronic neurodegenerative disease that usually starts slowly and gets worse over time. The most common early symptom is difficulty in remembering recent events (short-term memory loss). As the disease advances, symptoms can include problems with language, disorientation (including easily getting lost), mood swings, loss of motivation, not managing self care, and behavioural issues. As a person's condition declines, they often withdraw from family and society. Gradually, bodily functions are lost, ultimately leading to death. Although the speed of progression can vary, the average life expectancy following diagnosis is three to nine years.The cause of Alzheimer's disease is poorly understood. About 70% of the risk is believed to be genetic with many genes usually involved. Other risk factors include a history of head injuries, depression, or hypertension. The disease process is associated with plaques and tangles in the brain. A probable diagnosis is based on the history of the illness and cognitive testing with medical imaging and blood tests to rule out other possible causes. Initial symptoms are often mistaken for normal ageing. Examination of brain tissue is needed for a definite diagnosis. Mental and physical exercise, and avoiding obesity may decrease the risk of AD. There are no medications or supplements that decrease risk.No treatments stop or reverse its progression, though some may temporarily improve symptoms. Affected people increasingly rely on others for assistance, often placing a burden on the caregiver; the pressures can include social, psychological, physical, and economic elements. Exercise programs are beneficial with respect to activities of daily living and can potentially improve outcomes. Treatment of behavioral problems or psychosis due to dementia with antipsychotics is common but not usually recommended due to there often being little benefit and an increased risk of early death.In 2010, there were between 21 and 35 million people worldwide with AD. It most often begins in people over 65 years of age, although 4% to 5% of cases are early-onset Alzheimer's which begin before this. It affects about 6% of people 65 years and older. In 2010, dementia resulted in about 486,000 deaths. It was first described by, and later named after, German psychiatrist and pathologist Alois Alzheimer in 1906. In developed countries, AD is one of the most financially costly diseases.
  • studyres.com © 2026
  • DMCA
  • Privacy
  • Terms
  • Report